Your browser doesn't support javascript.
loading
Randomized phase Ib/II trial of rilotumumab or ganitumab with panitumumab versus panitumumab alone in patients with wild-type KRAS metastatic colorectal cancer.
Van Cutsem, Eric; Eng, Cathy; Nowara, Elzbieta; Swieboda-Sadlej, Anna; Tebbutt, Niall C; Mitchell, Edith; Davidenko, Irina; Stephenson, Joe; Elez, Elena; Prenen, Hans; Deng, Hongjie; Tang, Rui; McCaffery, Ian; Oliner, Kelly S; Chen, Lisa; Gansert, Jennifer; Loh, Elwyn; Smethurst, Dominic; Tabernero, Josep.
Afiliación
  • Van Cutsem E; University Hospitals Gasthuisberg and KU Leuven, Leuven, Belgium; eric.vancutsem@uzleuven.be.
  • Eng C; University of Texas M.D. Anderson Cancer Center, Houston, Texas;
  • Nowara E; Instytut im. M. Sklodowskiej-Curie, Gliwice;
  • Swieboda-Sadlej A; Warszawski Uniwersytet Medyczny, Warszawa, Poland;
  • Tebbutt NC; Austin Health, Heidelberg, VIC, Australia;
  • Mitchell E; Thomas Jefferson University, Philadelphia, Pennsylvania;
  • Davidenko I; Krasnodar City Oncology Center, Krasnodar, Russia;
  • Stephenson J; Cancer Centers of the Carolinas, Greenville, South Carolina;
  • Elez E; Vall d'Hebron University Hospital and Vall d'Hebron Institute of Oncology (VHIO), Universitat Autònoma de Barcelona, Barcelona, Spain; and.
  • Prenen H; University Hospitals Gasthuisberg and KU Leuven, Leuven, Belgium;
  • Deng H; Amgen Inc., Thousand Oaks;
  • Tang R; Amgen Inc., Thousand Oaks;
  • McCaffery I; Amgen Inc., Thousand Oaks;
  • Oliner KS; Amgen Inc., Thousand Oaks;
  • Chen L; Amgen Inc., Thousand Oaks;
  • Gansert J; Amgen Inc., Thousand Oaks;
  • Loh E; Amgen Inc., South San Francisco, California;
  • Smethurst D; Amgen Ltd., London, United Kingdom.
  • Tabernero J; Vall d'Hebron University Hospital and Vall d'Hebron Institute of Oncology (VHIO), Universitat Autònoma de Barcelona, Barcelona, Spain; and.
Clin Cancer Res ; 20(16): 4240-50, 2014 Aug 15.
Article en En | MEDLINE | ID: mdl-24919569

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neoplasias Colorrectales / Protocolos de Quimioterapia Combinada Antineoplásica / Proteínas Proto-Oncogénicas / Proteínas ras / Neoplasias Hepáticas / Recurrencia Local de Neoplasia Tipo de estudio: Clinical_trials / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Clin Cancer Res Asunto de la revista: NEOPLASIAS Año: 2014 Tipo del documento: Article

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neoplasias Colorrectales / Protocolos de Quimioterapia Combinada Antineoplásica / Proteínas Proto-Oncogénicas / Proteínas ras / Neoplasias Hepáticas / Recurrencia Local de Neoplasia Tipo de estudio: Clinical_trials / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Clin Cancer Res Asunto de la revista: NEOPLASIAS Año: 2014 Tipo del documento: Article